Tags : Alcon

Top 20 Medical Device Companies Based on 2019 Revenue

The Medical device market is growing with evolving needs of patients and with their emerging diseases encouraging them to develop novel and innovative therapies or devices for maintaining quality of life. The ledger for 2019 of medical devices has shown changes for multiple companies but the position for Medtronic remains same to be one top […]Read More

Alcon’s AcrySof IQ PanOptix Receives the US FDA’s Approval as

Shots: Alcon launches PanOptix Trifocal Intraocular Lens (IOL) to delivers a combination of near, intermediate and distance vision while reducing the need for glasses. Alcon plans to train US Ophthalmologist and to begin patient awareness program in H1’20 The approval of PanOptix is based on a pivotal study conducted at 12 sites in the US, […]Read More

PharmaShots Weekly Snapshot (August 19 – 23, 2019)

OxThera’s Oxabact Receives EMA’s Positive Decision on Pediatric Investigational Plan to Treat Primary Hyperoxaluria Published: Aug 23, 2019 | Tags: OxThera, Oxabact, Receives, EMA, Positive Decision, Pediatric Investigational Plan, Treat, Primary Hyperoxaluria 2.Novartis Signs an Option Agreement with Iconic Therapeutics for its Ophthalmology Program Published: Aug 22, 2019 | Tags: Novartis, Signs, Option Agreement, Iconic Therapeutics, Ophthalmology […]Read More

Top 20 Life Sciences Deals of 2018 Based on Total

Healthcare, pharmaceutical, and biotech companies are gearing up to tap new markets as they look to consolidate their positions after a spate of mergers & acquisitions and licensing partnerships in 2018. The highest valued deal proved to be of Takeda’s acquisition of Shire for $57B with the focus on global R&D, its robust and modality-diverse […]Read More

Alcon to Launch PRECISION1 Daily Disposable Contact Lenses in the

Shots: Alcon plans to launch its robust contact lens portfolio, PRECISION1 daily disposable, silicone hydrogel (SiHy) contact lenses in the US based on Alcon’s SMARTSURFACE technology which will enhance its DAILIES TOTAL1 and DAILIES AquaComfort PLUS contact lenses The clinical study evaluating PRECISION1 vs 1-Day ACUVUE Moist contact lenses, resulted in the superiority of PRECISION1 […]Read More

Alcon to Acquire PowerVision for $285M

Shots: Alcon acquires PowerVision, in all stock transaction paying $285M to PowerVision with additional payment based on regulatory & commercial milestones expected to initiate in 2023 The focus of the acquisition is to expand Alcon’s ophthalmic portfolio by using PowerVision’sadvanced technology intraocular lenses (AT-IOLS) to deliver therapies cataract surgery patients desiring spectacle independence PowerVision’s AT-IOLS […]Read More

Alcon to Acquire Tear Film Innovations for its iLux Medical

Shots: Alcon acquires Tear Film in all stock transaction with its iLux device, used for the treatment of Meibomian Gland Dysfunction The focus of the acquisition is to strengthen and expand Alcon’s ocular products in the US and Canada, including Tear’s iLux device for dry eye relief The iLux Device is an easy-to-use, portable medical device that directly helps in visualizing […]Read More

Verily (Alphabet’s Division) Holds its Smart Lens Project

Shots: The hold of the project is in response to the insufficient consistency in measurements between tear glucose and blood glucose levels for evaluation of device Glucose-Detecting Contact Lens was being developed to monitor the glucose levels in tears with help of sensors present in contact lens, which can further help to manage glucose level […]Read More

Alcon (Novartis Division) Plans to Develop SMART Suite Equipment for

Shots: The SMART Suite will be developed on Philips HealthSuite digital platform, providing services and technical tools to facilitate secure, open data exchange between facilities, clinicians and patients SMART Suite will be market-leading cataract refractive equipment connecting multiple diagnostic and surgical devices, providing easy access to patients’ data with simplified clinical process, consistency, greater efficiency […]Read More